Paul A. Mahon's most recent trade in United Therapeutics Corp was a trade of 8,300 shares done at an average price of $146.0 . Disclosure was reported to the exchange on Oct. 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| United Therapeutics Corp | Mr. Paul A. Mahon,J.D. | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 01 Oct 2026 | 8,300 | 53,472 (0%) | 0% | 146.0 | 1,212,049 | - |
| United Therapeutics Corp | Mr. Paul A. Mahon,J.D. | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 560.19 per share. | 01 Oct 2026 | 1,480 | 51,112 (0%) | 0% | 560.2 | 829,083 | - |
| United Therapeutics Corp | Mr. Paul A. Mahon,J.D. | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 563.09 per share. | 01 Oct 2026 | 1,480 | 48,852 (0%) | 0% | 563.1 | 833,374 | - |
| United Therapeutics Corp | Mr. Paul A. Mahon,J.D. | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 558.30 per share. | 01 Oct 2026 | 880 | 52,592 (0%) | 0% | 558.3 | 491,308 | - |
| United Therapeutics Corp | Mr. Paul A. Mahon,J.D. | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 570.90 per share. | 01 Oct 2026 | 838 | 46,155 (0%) | 0% | 570.9 | 478,411 | - |
| United Therapeutics Corp | Mr. Paul A. Mahon,J.D. | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 572.25 per share. | 01 Oct 2026 | 823 | 45,332 (0%) | 0% | 572.2 | 470,961 | - |
| United Therapeutics Corp | Mr. Paul A. Mahon,J.D. | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 561.87 per share. | 01 Oct 2026 | 780 | 50,332 (0%) | 0% | 561.9 | 438,259 | - |
| United Therapeutics Corp | Mr. Paul A. Mahon,J.D. | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 569.15 per share. | 01 Oct 2026 | 739 | 46,993 (0%) | 0% | 569.1 | 420,600 | - |
| United Therapeutics Corp | Mr. Paul A. Mahon,J.D. | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 567.76 per share. | 01 Oct 2026 | 720 | 47,732 (0%) | 0% | 567.8 | 408,788 | - |
| United Therapeutics Corp | Mr. Paul A. Mahon,J.D. | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 566.40 per share. | 01 Oct 2026 | 400 | 48,452 (0%) | 0% | 566.4 | 226,562 | - |
| United Therapeutics Corp | Mr. Paul A. Mahon,J.D. | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 573.15 per share. | 01 Oct 2026 | 160 | 45,172 (0%) | 0% | 573.2 | 91,704 | - |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Sep 2026 | 8,300 | 47,540 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 17 Sep 2026 | 8,300 | 53,472 (0%) | 0% | 146.0 | 1,212,049 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 496.58 per share. | 17 Sep 2026 | 2,873 | 49,020 (0%) | 0% | 496.6 | 1,426,662 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 495.97 per share. | 17 Sep 2026 | 1,579 | 51,893 (0%) | 0% | 496.0 | 783,132 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 497.54 per share. | 17 Sep 2026 | 1,400 | 47,620 (0%) | 0% | 497.5 | 696,561 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 499.75 per share. | 17 Sep 2026 | 1,160 | 45,617 (0%) | 0% | 499.8 | 579,712 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 498.74 per share. | 17 Sep 2026 | 843 | 46,777 (0%) | 0% | 498.7 | 420,435 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 501.58 per share. | 17 Sep 2026 | 320 | 45,172 (0%) | 0% | 501.6 | 160,506 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 500.80 per share. | 17 Sep 2026 | 125 | 45,492 (0%) | 0% | 500.8 | 62,600 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2026 | 8,300 | 55,840 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 03 Sep 2026 | 8,300 | 53,472 (0%) | 0% | 146.0 | 1,212,049 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 480.86 per share. | 03 Sep 2026 | 2,360 | 48,631 (0%) | 0% | 480.9 | 1,134,833 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 478.93 per share. | 03 Sep 2026 | 1,545 | 51,927 (0%) | 0% | 478.9 | 739,954 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 481.92 per share. | 03 Sep 2026 | 1,048 | 47,583 (0%) | 0% | 481.9 | 505,049 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 485.12 per share. | 03 Sep 2026 | 954 | 46,269 (0%) | 0% | 485.1 | 462,807 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 479.66 per share. | 03 Sep 2026 | 936 | 50,991 (0%) | 0% | 479.7 | 448,959 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 486.47 per share. | 03 Sep 2026 | 598 | 45,671 (0%) | 0% | 486.5 | 290,908 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 490.88 per share. | 03 Sep 2026 | 320 | 45,172 (0%) | 0% | 490.9 | 157,083 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 483.85 per share. | 03 Sep 2026 | 200 | 47,223 (0%) | 0% | 483.9 | 96,770 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 487.36 per share. | 03 Sep 2026 | 169 | 45,502 (0%) | 0% | 487.4 | 82,364 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 482.66 per share. | 03 Sep 2026 | 160 | 47,423 (0%) | 0% | 482.7 | 77,226 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 488.30 per share. | 03 Sep 2026 | 10 | 45,492 (0%) | 0% | 488.3 | 4,883 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 20 Aug 2026 | 5,610 | 53,472 (0%) | 0% | 146.0 | 819,228 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2026 | 5,610 | 64,140 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2026 | 2,690 | 0 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 524.15 per share. | 20 Aug 2026 | 2,690 | 50,782 (0%) | 0% | 524.2 | 1,409,964 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 20 Aug 2026 | 2,690 | 47,862 (0%) | 0% | 146.0 | 392,821 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 521.04 per share. | 20 Aug 2026 | 1,819 | 48,461 (0%) | 0% | 521.0 | 947,773 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 525.25 per share. | 20 Aug 2026 | 940 | 45,692 (0%) | 0% | 525.3 | 493,735 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 522.78 per share. | 20 Aug 2026 | 850 | 46,824 (0%) | 0% | 522.8 | 444,366 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 522.00 per share. | 20 Aug 2026 | 787 | 47,674 (0%) | 0% | 522.0 | 410,817 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 520.03 per share. | 20 Aug 2026 | 502 | 50,280 (0%) | 0% | 520.0 | 261,057 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 526.38 per share. | 20 Aug 2026 | 400 | 45,292 (0%) | 0% | 526.4 | 210,554 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 523.69 per share. | 20 Aug 2026 | 192 | 46,632 (0%) | 0% | 523.7 | 100,548 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 527.21 per share. | 20 Aug 2026 | 120 | 45,172 (0%) | 0% | 527.2 | 63,265 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 06 Aug 2026 | 8,300 | 53,472 (0%) | 0% | 146.0 | 1,212,049 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2026 | 8,300 | 72,440 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 514.82 per share. | 06 Aug 2026 | 1,795 | 50,917 (0%) | 0% | 514.8 | 924,106 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 516.93 per share. | 06 Aug 2026 | 1,617 | 47,940 (0%) | 0% | 516.9 | 835,869 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 515.93 per share. | 06 Aug 2026 | 1,360 | 49,557 (0%) | 0% | 515.9 | 701,665 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 521.50 per share. | 06 Aug 2026 | 1,308 | 45,492 (0%) | 0% | 521.5 | 682,118 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 517.94 per share. | 06 Aug 2026 | 780 | 47,160 (0%) | 0% | 517.9 | 403,994 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 512.92 per share. | 06 Aug 2026 | 760 | 52,712 (0%) | 0% | 512.9 | 389,817 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 518.82 per share. | 06 Aug 2026 | 360 | 46,800 (0%) | 0% | 518.8 | 186,776 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 522.39 per share. | 06 Aug 2026 | 320 | 45,172 (0%) | 0% | 522.4 | 167,166 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 16 Jul 2026 | 8,300 | 53,472 (0%) | 0% | 146.0 | 1,212,049 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2026 | 8,300 | 80,740 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 534.21 per share. | 16 Jul 2026 | 3,279 | 47,812 (0%) | 0% | 534.2 | 1,751,679 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 534.99 per share. | 16 Jul 2026 | 1,519 | 45,252 (0%) | 0% | 535.0 | 812,648 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 535.88 per share. | 16 Jul 2026 | 1,041 | 46,771 (0%) | 0% | 535.9 | 557,851 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 531.97 per share. | 16 Jul 2026 | 861 | 51,891 (0%) | 0% | 532.0 | 458,025 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 532.94 per share. | 16 Jul 2026 | 800 | 51,091 (0%) | 0% | 532.9 | 426,352 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 527.60 per share. | 16 Jul 2026 | 600 | 52,872 (0%) | 0% | 527.6 | 316,557 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 529.81 per share. | 16 Jul 2026 | 120 | 52,752 (0%) | 0% | 529.8 | 63,577 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 536.85 per share. | 16 Jul 2026 | 80 | 45,172 (0%) | 0% | 536.9 | 42,948 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 02 Jul 2026 | 8,300 | 53,472 (0%) | 0% | 146.0 | 1,212,049 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jul 2026 | 8,300 | 89,040 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 553.52 per share. | 02 Jul 2026 | 2,201 | 46,686 (0%) | 0% | 553.5 | 1,218,290 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 552.61 per share. | 02 Jul 2026 | 1,818 | 48,887 (0%) | 0% | 552.6 | 1,004,639 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 551.30 per share. | 02 Jul 2026 | 1,467 | 50,705 (0%) | 0% | 551.3 | 808,751 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 555.83 per share. | 02 Jul 2026 | 990 | 45,397 (0%) | 0% | 555.8 | 550,267 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 548.00 per share. | 02 Jul 2026 | 658 | 52,814 (0%) | 0% | 548.0 | 360,585 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 550.02 per share. | 02 Jul 2026 | 384 | 52,172 (0%) | 0% | 550.0 | 211,209 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 554.44 per share. | 02 Jul 2026 | 299 | 46,387 (0%) | 0% | 554.4 | 165,779 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 548.73 per share. | 02 Jul 2026 | 258 | 52,556 (0%) | 0% | 548.7 | 141,573 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 556.36 per share. | 02 Jul 2026 | 225 | 45,172 (0%) | 0% | 556.4 | 125,181 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2026 | 8,300 | 97,340 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 18 Jun 2026 | 8,300 | 53,472 (0%) | 0% | 146.0 | 1,212,049 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 537.04 per share. | 18 Jun 2026 | 1,715 | 51,757 (0%) | 0% | 537.0 | 921,027 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 539.42 per share. | 18 Jun 2026 | 1,305 | 49,494 (0%) | 0% | 539.4 | 703,937 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 538.03 per share. | 18 Jun 2026 | 958 | 50,799 (0%) | 0% | 538.0 | 515,431 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 541.25 per share. | 18 Jun 2026 | 950 | 47,746 (0%) | 0% | 541.3 | 514,192 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 547.65 per share. | 18 Jun 2026 | 881 | 46,068 (0%) | 0% | 547.6 | 482,476 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 540.25 per share. | 18 Jun 2026 | 798 | 48,696 (0%) | 0% | 540.2 | 431,118 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 548.91 per share. | 18 Jun 2026 | 496 | 45,572 (0%) | 0% | 548.9 | 272,261 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 544.26 per share. | 18 Jun 2026 | 480 | 47,106 (0%) | 0% | 544.3 | 261,246 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 551.74 per share. | 18 Jun 2026 | 400 | 45,172 (0%) | 0% | 551.7 | 220,696 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 541.95 per share. | 18 Jun 2026 | 160 | 47,586 (0%) | 0% | 542.0 | 86,712 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 546.15 per share. | 18 Jun 2026 | 157 | 46,949 (0%) | 0% | 546.1 | 85,745 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 04 Jun 2026 | 8,300 | 53,472 (0%) | 0% | 146.0 | 1,212,049 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2026 | 8,300 | 105,640 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 546.42 per share. | 04 Jun 2026 | 2,627 | 49,431 (0%) | 0% | 546.4 | 1,435,440 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 548.42 per share. | 04 Jun 2026 | 1,481 | 47,015 (0%) | 0% | 548.4 | 812,217 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 549.47 per share. | 04 Jun 2026 | 1,250 | 45,172 (0%) | 0% | 549.5 | 686,838 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 547.11 per share. | 04 Jun 2026 | 935 | 48,496 (0%) | 0% | 547.1 | 511,549 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 543.89 per share. | 04 Jun 2026 | 840 | 52,432 (0%) | 0% | 543.9 | 456,867 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 549.49 per share. | 04 Jun 2026 | 593 | 46,422 (0%) | 0% | 549.5 | 325,850 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 545.27 per share. | 04 Jun 2026 | 374 | 52,058 (0%) | 0% | 545.3 | 203,930 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 539.76 per share. | 04 Jun 2026 | 200 | 53,272 (0%) | 0% | 539.8 | 107,952 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2026 | 8,300 | 113,940 | - | - | Stock Option |